Mỹ đồng ý chi hơn 1 tỷ USD mua thuốc điều trị COVID-19 của Merck & Co

Ngày 9/6, hãng dược phẩm Merck & Co Inc cho biết Chính phủ Mỹ đã nhất trí chi khoảng 1,2 tỷ USD để mua 1,7 triệu liệu trình thuốc Molnupiravir đang được thử nghiệm điều trị bệnh COVID-19, nếu cuộc thử nghiệm quy mô lớn hiện nay cho thấy thuốc có tác dụng và được cơ quan quản lý dược phẩm Mỹ cấp phép.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chứng nhận tín nhiệm mạng
POWERED BY Việt Long